Tryptamine Therapeutics Limited Share Price
Equities
TYP
AU0000331993
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0275 AUD | 0.00% | 0.00% | 0.00% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 7.29M 5.33M 8.05M 419M |
---|---|---|---|---|---|
Net income 2024 * | -5M -3.66M -5.52M -287M | Net income 2025 * | -5M -3.66M -5.52M -287M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 0 | Net cash position 2025 * | - 0 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.31% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 4.28M | |
+65.76% | 62.86B | |
-0.89% | 41.38B | |
+45.72% | 40.38B | |
-8.93% | 27.64B | |
+12.94% | 26.46B | |
-22.51% | 18.9B | |
+3.69% | 12.67B | |
+25.13% | 12.27B | |
+27.97% | 12.07B |
- Stock Market
- Equities
- TYP Stock